Similar articles

• The treatment of common dermatoses with topically applied 0.05 per cent desonide cream. A paired-comparison clinical study.

  Reque PG. Reque PG. J Med Assoc State Ala. 1972 Jul;42(1):25-7. J Med Assoc State Ala. 1972. PMID: 4558013 Clinical Trial. No abstract available.
• Double-blind clinical comparisons of topical betamethasone valerate and betamethasone benzoate in the treatment of steroid-responsive dermatoses.

  Hall-Smith P. Hall-Smith P. Br J Clin Pract. 1972 Sep;26(9):422-3. Br J Clin Pract. 1972. PMID: 4562674 Clinical Trial. No abstract available.
• A clinical evaluation of 0.05 per cent desonide cream. A new nonfluorinated topical corticosteroid.

  Gentry WC Jr, Rosenberg EW, Goltz RW. Gentry WC Jr, et al. Arch Dermatol. 1973 Jun;107(6):870-1. Arch Dermatol. 1973. PMID: 4575947 Clinical Trial. No abstract available.
• Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety.

  Goustas P, Cork MJ, Higson D. Goustas P, et al. J Dermatolog Treat. 2003 Jun;14(2):71-85. doi: 10.1080/09546630310004180. J Dermatolog Treat. 2003. PMID: 12775314 Review.
• The modern topical steroid.

  Lee SS, Rapp Y. Lee SS, et al. Int J Dermatol. 1975 Jul-Aug;14(6):412-21. doi: 10.1111/j.1365-4362.1975.tb00131.x. Int J Dermatol. 1975. PMID: 1099029 Review. No abstract available.